✦ LIBER ✦

Farewell to the Italian journal of gastroenterology and hepatology. Welcome to digestive and liver disease!

✍ Scribed by G. Bianchi Porro; F. Bonino

Book ID: 119629470
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 138 KB
Volume: 32
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(00)80035-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The significance of alcoholic liver dise

The significance of alcoholic liver disease to contemporary clinical hepatology

✍ N Bach 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Minuk report are clearly influenced by the design of their study. Accordingly, several points require amplification and comment. In the public perception, liver disease has long been associ- The first issue worthy of scrutiny is the set of criteria used ated with alcohol abuse. This perception stig

The significance of alcoholic liver dise

The significance of alcoholic liver disease to contemporary clinical hepatology

✍ N Bach 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

American Gastroenterological Association

American Gastroenterological Association Future Trends Committee Report: The Application of Genomic and Proteomic Technologies to Digestive Disease Diagnosis and Treatment and Their Likely Impact on Gastroenterology Clinical Practice

✍ Konstantinos N. Lazaridis; Brian D. Juran 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 848 KB

Transmission of hepatitis B by transplan

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database

✍ RC Dickson; JE Everhart; JR Lake; Y Wei; EC Seaberg; RH Wiesner; RK Zetterman; T 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Design and rationale of the WELCOME tria

Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty liver disease

✍ Scorletti, E.; Bhatia, L.; McCormick, K.G.; Clough, G.F.; Nash, K.; Calder, P.C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 372 KB

‘Corrigendum to “Design and rationale of

‘Corrigendum to “Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty liver disease” [Contemp Clin Trials 37 (2) (2014) 301–311]’

✍ Scorletti, E.; Bhatia, L.; McCormick, K.G.; Clough, G.F.; Nash, K.; Calder, P.C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 125 KB